Citations

Clear

16280 citation(s) found for "Yu, David".

Reply to M. Buyse et al
Hoff, Daniel D. Von , Sutherland, William, Rosen, Peter J., Loesch, David, Borad, Mitesh J.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2011 | Volume: 29 | Issue: 15 | Pages: e453-e453

10.1200/jco.2011.34.8946 Get It

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
Cavo, Michèle , Rajkumar, S. Vincent , Palumbo, Antonio , Moreau, Philippe , Orlowski, Robert Z. , Bladé, Joan , Sezer, Orhan , Dimopoulos, Meletios Α. , Sonneveld, Pieter , Boccadoro, Mario , Richardson, Paul G. , Bensinger, William, Johnsen, Hans Erik , Gahrton, Gösta , Bergsagel, P. Leif , Vesole, David H., Niesvizky, Rubén, Durie, Brian G.M. , Miguel, Jesús F. San , Bergsagel, P. Leif , Orlowski, Robert Z. , Ludwig, Heinz , Attal, Michel , Anderson, Kenneth C. , Richardson, Paul Gerard Guy , Kröger, Nicolaus , Einsele, Hermann , Jagannath, Sundar , Lonial, Sagar , Rajkumar, S Vincent , Dimopoulos, Meletios A , Moreau, Philippe , San-Miguel, Jesus

Mayo Clinic

Blood | March 30, 2011 | Volume: 117 | Issue: 23 | Pages: 6063-6073

10.1182/blood-2011-02-297325 | PMID 21447828 Get It

AbstractThe role of high-dose therapy followed by autologous stem cell transplantation (ASCT) in the treatment of multiple myeloma (MM) continues to evolve in the novel agent era. The choice of induction therapy has moved from conventional chemotherapy to newer regimens incorporating the immunomodulatory derivatives thalidomide or lenalidomide and the proteasome inhibitor bortezomib. These drugs combine well with traditional therapies and with one another to form various doublet, triplet, and quadruplet regimens. Up-front use of these induction treatments, in particular 3-drug combinations, has affected unprecedented rates of complete response that rival those previously seen with conventional chemotherapy and subsequent ASCT. Autotransplantation applied after novel-agent-based induction regimens provides further improvement in the depth of response, a gain that translates into extended progression-free survival and, potentially, overall survival. High activity shown by immunomodulatory derivatives and bortezomib before ASCT has recently led to their use as consolidation and maintenance therapies after autotransplantation. Novel agents and ASCT are complementary treatment strategies for MM. This article reviews the current literature and provides important perspectives and guidance on the major issues surrounding the optimal current management of younger, transplantation-eligible MM patients.
Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies
Meng, Ian D., Ossipov, Michael H. , Dodick, David W. , Porreca, Frank

Mayo Clinic

Cephalalgia | March 28, 2011 | Volume: 31 | Issue: 7 | Pages: 851-860

10.1177/0333102411402367 | PMID 21444643 Get It

Introduction: Medication overuse headache (MOH) is a clinical concern in the management of migraine headache. MOH arises from the frequent use of medications used for the treatment of a primary headache. Medications that can cause MOH include opioid analgesics as well as formulations designed for the treatment of migraine, such as triptans, ergot alkaloids, or drug combinations that include caffeine and barbiturates. Literature review: Gathering evidence indicates that migraine patients are more susceptible to development of MOH, and that prolonged use of these medications increases the prognosis for development of chronic migraine, leading to the suggestion that similar underlying mechanisms may drive both migraine headache and MOH. In this review, we examine the link between several mechanisms that have been linked to migraine headache and a potential role in MOH. For example, cortical spreading depression (CSD), associated with migraine development, is increased in frequency with prolonged use of topiramate or paracetamol. Conclusions: Increased CGRP levels in the blood have been linked to migraine and elevated CGRP can be casued by prolonged sumatriptan exposure. Possible mechanisms that may be common to both migraine and MOH include increased endogenous facilitation of pain and/or diminished diminished endogenous pain inhibition. Neuroanatomical pathways mediating these effects are examined.
Effect of Age on Outcomes of Treatment of Unruptured Cerebral Aneurysms
Brinjikji, Waleed , Kallmes, David F. , Cloft, Harry J. , Rabinstein, Alejandro A. , Lanzino, Giuseppe

Mayo Clinic

Stroke | March 25, 2011 | Volume: 42 | Issue: 5 | Pages: 1320-1324

10.1161/strokeaha.110.607986 | PMID 21441142 Get It

Background and Purpose— Age might differentially affect outcomes in patients treated for unruptured cerebral aneurysms with surgical clipping versus endovascular coil therapy. We evaluated a large administrative database to determine the effect of age on outcomes in patients treated for unruptured cerebral aneurysm. Methods— Using the National Inpatient Sample, we evaluated morbidity (discharge to long-term facility) and mortality of patients undergoing clipping or coiling of unruptured cerebral aneurysms in the United States between 2001 and 2008. Outcomes were evaluated in relation to four age strata: younger than 50 years; 50 to 64 years; 65 to 79 years; and patients 80 years or older. Results— Patients younger than 50 years old undergoing coiling had significantly lower morbidity rates when compared to patients who underwent clipping (3.5% versus 8.1%; P <0.0001), but no difference in mortality (0.6% versus 0.6%; P =0.72). Patients between 50 and 64 years old undergoing coiling had significantly decreased morbidity (4.0% versus 13.7%; P <0.0001) and mortality (0.5% versus 1.1%; P <0.0001) when compared to patients who underwent clipping. Coiled patients 65 to 79 years old had lower morbidity (6.9% versus 26.8%; P <0.0001) and mortality (0.8% versus 2.0%; P <0.0001) compared to patients who underwent clipping. Patients aged 80 years or older undergoing coiling also had lower morbidity (9.8% versus 33.5%; P <0.0001) and mortality (2.4% versus 21.4%; P <0.0001) when compared to patients who have undergone clipping. Conclusions— Patients treated with endovascular coiling have significantly less morbidity and mortality than those treated with surgical clipping, and these differences become more pronounced with age.
The Lack of Growth in Use of Coronary CT Angiography: Is It Being Appropriately Used?
Levin, David C. , Parker, Laurence, Halpern, Ethan J. , Julsrud, Paul R., Rao, Vijay M.

Mayo Clinic

American Journal of Roentgenology | March 22, 2011 | Volume: 196 | Issue: 4 | Pages: 862-867

10.2214/ajr.10.5236 | PMID 21427337 Get It

Cardiac Sympathetic Reserve and Response to Cardiac Resynchronization Therapy
Cha, Yong‐Mei , Dong, Ying-Xue, Kemp, Bradley J. , Oh, Jae K. , Miyazaki, Chinami , Hayes, David L. , Rea, Robert F., Asirvatham, Samuel J. , Webster, Tracy L., Dalzell, Connie, Hodge, David O. , Herges, Regina M., Yong, Yan-zhong, Zhang, Yanhua, Chen, Peng‐Sheng , Chareonthaitawee, Panithaya , Zhang, Yanhua, Asirvatham, Samuel J

Mayo Clinic

Circulation: Heart Failure | March 19, 2011 | Volume: 4 | Issue: 3 | Pages: 339-344

10.1161/circheartfailure.110.959858 | PMID 21421772 Get It

Background— The objective of the present study was to investigate the effect of cardiac resynchronization therapy (CRT) on cardiac autonomic function. Methods and Results— This prospective study included 45 consecutive patients with heart failure who received CRT devices with defibrillator and 20 age-matched, healthy control subjects. At baseline and 3 months and 6 months after CRT, we assessed New York Heart Association (NYHA) class, 6-minute walk distance, plasma sympathetic biomarker nerve growth factor, echocardiography, heart rate variability and cardiac presynaptic sympathetic function determined by iodine 123 metaiodobenzylguanidine scintigraphy. After CRT, NYHA class improved by 1 class ( P <0.001), and left ventricular ejection fraction increased by 8% ( P <0.001). Along with improvement in the standard deviation of all normal-to-normal R-R intervals (85.63±31.66 ms versus 114.79±38.99 ms; P =0.004) and the standard deviation of the averaged normal-to-normal R-R intervals (82.62±23.03 ms versus 100.50±34.87 ms; P =0.004), the delayed heart/mediastinum (H/M) ratio increased (1.82 [0.58] versus 1.97 [0.59]; P =0.03), whereas the mean (SD) H/M washout rate was reduced (48% [19%] versus 37% [22%]; P =0.01). Twenty-two of 45 study patients responded to CRT, with a reduction of left ventricular end-systolic volume index >15%. Compared with nonresponders, responders had a higher delayed H/M ratio (2.11 versus 1.48; P =0.003) and lower H/M washout rate (37% versus 62%; P =0.003) at baseline. Conclusions— CRT improved sympathetic function. Cardiac sympathetic reserve may be a marker for the reversibility of failing myocardial function.
CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma
Burington, Bart, Peng, Yue , Shi, Xiaoyan , Advani, Ranjana H. , Lau, Jeffrey , Stinson, Susanna, Stinson, Jeremy, Januario, Thomas, Vos, Sven de , Ansell, Stephen M. , Forero‐Torres, Andres , Fedorowicz, Grazyna, Yang, Teddy , Elkins, Kristi , Du, Changchun, Mohan, Sankar, Modrušan, Zora , Seshagiri, Somasekar , Yu, Shang‐Fan , Pandita, Ajay , Koeppen, Hartmut , French, Dorothy, Polson, Andrew G. , Offringa, Rienk , Whiting, Nancy, Ebens, Allen , Dornan, David, Tan, Jenille , Yu, Nancy , Advani, Ranjana H , Modrusan, Zora

Mayo Clinic

Science Translational Medicine | March 16, 2011 | Volume: 3 | Issue: 74 | Pages: No page available

10.1126/scitranslmed.3001620 | PMID 21411738 Get It

A 15-gene expression signature predicts whether a patient with diffuse large B cell lymphoma will respond to dacetuzumab, a therapeutic antibody.
Cochlear Implantation in Developing Countries as Humanitarian Service
Saunders, James E., Barrs, David M.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | March 12, 2011 | Volume: 145 | Issue: 1 | Pages: 74-79

10.1177/0194599811401343 | PMID 21493294 Get It

ObjectiveTo make recommendations concerning cochlear implantation during humanitarian medical trips by exploring the attitudes of US cochlear implant surgeons.Study DesignCross‐sectional survey.SettingAcademic.Subjects and MethodsQuestionnaires were sent to 405 members of the William House Cochlear Implant Study Group. The 198 respondents (49%), all active cochlear implant surgeons, were divided into 3 groups depending on their level of experience working in a developing country.ResultsEighty‐nine percent of respondents supported cochlear implants in these environments, although 42% of these cochlear implant surgeons stated that they would modify their criteria for implantation considering the challenges in developing countries. There was strong support for cochlear implants in postlingual deafened patients and prelingual deafened patients under the age of 3 years, although nearly half of respondents (48%) would not implant prelingual deafened patients after they reached the age of 3 years. Three‐quarters of respondents (74%) believed that developing countries should have the same access to current multichannel devices used in developed countries, as opposed to simpler, possibly lower cost devices. A local audiologist was deemed the most important personnel requirement (83%), and limited audiology and rehabilitative resources were the greatest postoperative concern rather than lack of postoperative care or infection.ConclusionThis survey strongly supports the practice of performing cochlear implants during humanitarian trips to developing countries and makes best‐practice recommendations to make outcomes successful.
Hydrogen sulfide is a partially redox-independent activator of the human jejunum Na+ channel, Nav1.5
Strege, Peter R. , Bernard, Cheryl E., Kraichely, Robert E., Mazzone, Amelia , Sha, Lei , Gibbons, Simon J. , Kendrick, Michael L. , Sarr, Michael G. , Szurszewski, Joseph H., Farrugia, Gianrico , Beyder, Arthur , Linden, David R. , Gibbons, S J , Strege, Peter R , Mazzone, Amelia

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | March 11, 2011 | Volume: 300 | Issue: 6 | Pages: G1105-G1114

10.1152/ajpgi.00556.2010 | PMID 21393430 Get It

Hydrogen sulfide (H2S) is produced endogenously by l-cysteine metabolism. H2S modulates several ion channels with an unclear mechanism of action. A possible mechanism is through reduction-oxidation reactions attributable to the redox potential of the sulfur moiety. The aims of this study were to determine the effects of the H2S donor NaHS on NaV1.5, a voltage-dependent sodium channel expressed in the gastrointestinal tract in human jejunum smooth muscle cells and interstitial cells of Cajal, and to elucidate whether H2S acts on NaV1.5 by redox reactions. Whole cell Na+ currents were recorded in freshly dissociated human jejunum circular myocytes and NaV1.5-transfected human embryonic kidney-293 cells. RT-PCR amplified mRNA for H2S enzymes cystathionine β-synthase and cystathionine γ-lyase from the human jejunum. NaHS increased native Na+ peak currents and shifted the half-point ( V1/2) of steady-state activation and inactivation by +21 ± 2 mV and +15 ± 3 mV, respectively. Similar effects were seen on the heterologously expressed NaV1.5 α subunit with EC50s in the 10−4 to 10−3 M range. The reducing agent dithiothreitol (DTT) mimicked in part the effects of NaHS by increasing peak current and positively shifting steady-state activation. DTT together with NaHS had an additive effect on steady-state activation but not on peak current, suggesting that the latter may be altered via reduction. Pretreatment with the Hg2+-conjugated oxidizer thimerosal or the alkylating agent N-ethylmaleimide inhibited or decreased NaHS induction of NaV1.5 peak current. These studies show that H2S activates the gastrointestinal Na+ channel, and the mechanism of action of H2S is partially redox independent.
A Bivariate Genome-Wide Approach to Metabolic Syndrome
Kraja, Aldi T., Vaidya, Dhananjay , Pankow, James S. , Goodarzi, Mark O., Assimes, Themistocles L. , Sovio, Ulla , Mathias, Rasika A. , Sun, Yan V. , Franceschini, Nora , Absher, Devin , Zhang, Qunyuan, Feitosa, Mary F. , Glazer, Nicole L. , Hartikainen, Anna-Liisa, Knowles, Joshua W. , Iribarren, Carlos , Kral, Brian G. , Yanek, Lisa R. , O’Reilly, Paul F. , McCarthy, Mark I. , Jaquish, Cashell E. , Couper, David , Chakravarti, Aravinda , Becker, Lewis C. , Province, Michael A. , Boerwinkle, Eric , Quertermous, Thomas , Palotie, L, Järvelin, Marjo‐Riitta , Becker, Diane M. , Kardia, Sharon L. R., Rotter, Jerome I. , Chen, Yii-Der Ida , Borecki, Ingrid B. , Goodarzi, Mark O. , Kullo, Iftikhar J. , Guo, Li , Haritunians, Talin , Hartikainen, Anna‐Liisa, North, Kari E. , Psaty, Bruce M. , McCarthy, Mark I , Assimes, Themistocles L , Rotter, Jerome I , Mathias, Rasika A , Pankow, James S , Couper, David , Province, Mike

Mayo Clinic

Diabetes | March 9, 2011 | Volume: 60 | Issue: 4 | Pages: 1329-1339

10.2337/db10-1011 | PMID 21386085 Get It

OBJECTIVE The metabolic syndrome (MetS) is defined as concomitant disorders of lipid and glucose metabolism, central obesity, and high blood pressure, with an increased risk of type 2 diabetes and cardiovascular disease. This study tests whether common genetic variants with pleiotropic effects account for some of the correlated architecture among five metabolic phenotypes that define MetS. RESEARCH DESIGN AND METHODS Seven studies of the STAMPEED consortium, comprising 22,161 participants of European ancestry, underwent genome-wide association analyses of metabolic traits using a panel of ∼2.5 million imputed single nucleotide polymorphisms (SNPs). Phenotypes were defined by the National Cholesterol Education Program (NCEP) criteria for MetS in pairwise combinations. Individuals exceeding the NCEP thresholds for both traits of a pair were considered affected. RESULTS Twenty-nine common variants were associated with MetS or a pair of traits. Variants in the genes LPL, CETP, APOA5 (and its cluster), GCKR (and its cluster), LIPC, TRIB1, LOC100128354/MTNR1B, ABCB11, and LOC100129150 were further tested for their association with individual qualitative and quantitative traits. None of the 16 top SNPs (one per gene) associated simultaneously with more than two individual traits. Of them 11 variants showed nominal associations with MetS per se. The effects of 16 top SNPs on the quantitative traits were relatively small, together explaining from ∼9% of the variance in triglycerides, 5.8% of high-density lipoprotein cholesterol, 3.6% of fasting glucose, and 1.4% of systolic blood pressure. CONCLUSIONS Qualitative and quantitative pleiotropic tests on pairs of traits indicate that a small portion of the covariation in these traits can be explained by the reported common genetic variants.